Paper
Paper
Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-d-glutamyl-l-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis
Alterovitz G, Tuthill C, Rios I, Modelska K, Sonis S. 2011. Personalized medicine for mucositis: Bayesian networks identify unique gene clusters, which predict the response to gamma-D-glutamyl-L-tryptophan (SCV-07) for the attenuation of chemoradiation-induced OM. Oral Oncol. 2011;47:951-5.
Paper
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines
Peterson DE, Bensadoun RJ, Roila F. Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Annals of Oncology 22. 2011; Supplement 6: vi78–vi84.
Paper
Structure of RiVax: a recombinant ricin vaccine
Legler, P.M., et al., Structure of RiVax: a recombinant ricin vaccine. Acta Crystallogr D Biol Crystallogr, 2011. 67(Pt 9): p. 826-30.
Paper
Ricin Vaccine Development
Smallshaw, J.E. and E.S. Vitetta, Ricin Vaccine Development. Curr Top Microbiol Immunol, 2012. 357: p. 259-72.
Paper
Beclomethasone dipropionate in Crohn’s ileitis: A randomised, double-blind trial. Digestive and Liver Disease
Prantera C, Rizzi M, Cottone M, et al. Beclomethasone dipropionate in Crohn’s ileitis: A randomised, double-blind trial. Digestive and Liver Disease. 2011; 43:459-464.
Paper
Protective immunity to ricin toxin conferred by antibodies against the toxin’s binding subunit (RTB)
Yermakova, A. and N.J. Mantis, Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB). Vaccine, 2011. 29(45): p. 7925-35.
Paper
Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay
Porter, A., et al., Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay. Toxicon, 2011. 58(1): p. 68-75.
Paper
Protective Effect of Two Recombinant Ricin Subunit Vaccines in the New Zealand White Rabbit Subjected to a Lethal Aerosolized Ricin Challenge: Survival, Immunological Response and Histopathological Findings
McLain, D.E., et al., Protective Effect of Two Recombinant Ricin Subunit Vaccines in the New Zealand White Rabbit Subjected to a Lethal Aerosolized Ricin Challenge: Survival, Immunological Response and Histopathological Findings. Toxicol Sci, 2011.
Paper
Process development and cGMP manufacturing of a recombinant ricin vaccine: An effective and stable recombinant ricin a-chain vaccine-RVEc
Meagher, M.M., et al., Process development and cGMP manufacturing of a recombinant ricin vaccine: An effective and stable recombinant ricin a-chain vaccine-RVEc. Biotechnol Prog, 2011.
Paper
Progress in Biological Threat Agent Vaccine Development: A Repeat-Dose Toxicity Study of a Recombinant Ricin Toxin A-Chain (rRTA) 1-33/44-198 Vaccine (RVEc) in Male and Female New Zealand White Rabbits
McLain, D.E., et al., Progress in Biological Threat Agent Vaccine Development: A Repeat-Dose Toxicity Study of a Recombinant Ricin Toxin A-Chain (rRTA) 1-33/44-198 Vaccine (RVEc) in Male and Female New Zealand White Rabbits. Int J Toxicol, 2011.